WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Live Video Detailing Scores High Marks with Physicians

Details
Research
25 March 2009
Manhattan ResearchThough video detailing had a rocky start when it debuted a decade ago, recent physician online video adoption and satisfaction rates indicate that this channel is now a viable option for pharma, biotech, and device manufacturers.
Read more ...

Pleasant music can enhance visual awareness in stroke patients, study shows

Details
Research
25 March 2009
Researchers in Spain and the UK have demonstrated that stroke patients who have lost part of their spatial awareness experience enhanced visual awareness when listening to music that they like. The study's findings, published in the Proceedings of the National Academy of Sciences, underline the importance of an individual's emotional state in modulating awareness.
Read more ...

Project Launched by VTT Develops Computer Models for Predicting Dietary Effects on Health

Details
Research
16 March 2009
VTT is launching an extensive EU project called ETHERPATHS, studying the effects of dietary effects mediated by gut microbiota on lipid metabolism. The aim is to accelerate the development of health-promoting foods. The project develops computer assisted models with which food companies and research institutions, for instance, will be able to predict the effects of foods in the body.
Read more ...

The Five Myths of Generic Competition

Details
Research
13 March 2009
The Healthcare and Science business of Thomson Reuters has released the white paper, "The Five Myths of Generic Competition," highlighting what originator pharmaceutical and biotech companies can do to improve their forecasting of the likely timing, source and intensity of competition from generic drugs.
Read more ...

New communication opportunities for providers of medical scientific information

Details
Research
07 March 2009
Deutsche Zeitschrift für Klinische Forschung (DZKF) portal, developed by Geelen & Geelen Beratung für medizinisch-wissenschaftliche Projekte GmbH, now is available in English. The portal is password protected and accessible only by medical scientific professionals, it allows to publish and read multimedia-format information and send others the related web link(s).
Read more ...

Three Ways for Pharma Product Sites to Improve Visitor Satisfaction and Retain Consumers

Details
Research
06 March 2009
Manhattan ResearchPharmaceutical product sites are an important component of an overall brand strategy and can serve as a brand extender for consumers - providing an engaging brand experience that may not be fully realized in the time and space constraints of traditional media.
Read more ...

U.S. Adults With Diabetes Take Control of Care Through Innovative Use of Digital Resources

Details
Research
03 March 2009
Manhattan ResearchMore than ever, type 1 and type 2 diabetes patients are turning to online channels to research treatment and product information, to seek advice and support from others, and to manage their condition. According to pharmaceutical and healthcare market research company Manhattan Research's Cybercitizen Health™ study, nine out of ten online diabetes patients use the Internet to research health information, and two-thirds use the Internet to access pharmaceutical product information.
Read more ...

More Pharma News ...

  1. Biopharmaceutical Companies Risk Delays in Producing Targeted Treatment Solutions
  2. Heart attacks linked with antiretroviral treatment
  3. Study highlights tragedy of avoidable adverse drug reactions
  4. Key Demographics and Behaviors for Consumers Using Search Engines for Online Health and Pharma Info
  5. The Future of Mobile Health: Mobile Adoption, mHealth and Mobile Marketing
  6. Manhattan Research Releases Top Pharma Brand Product Sites by Consumer Satisfaction
  7. Magnetic Resonance Imaging to Assess the Effect of Therapy
  • Start
  • Prev
  • 289
  • 290
  • 291
  • 292
  • 293
  • 294
  • 295
  • 296
  • 297
  • 298
  • Next
  • End

Business & Industry

  • CPHI Pharma Awards open to global innovators, scientists, entrepreneurs and social leaders
  • Insilico Medicine brings AI-powered "ChatPandaGPT" to its target discovery platform
  • BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson's disease clinical trial
  • Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma
  • AstraZeneca launches call for entries to the 2023 global R&D Postdoctoral Challenge

Research & Development

  • 'Biohybrid' device could restore function in paralysed limbs
  • Scientists use tardigrade proteins for human health breakthrough
  • DNA treatment could delay paralysis that strikes nearly all patients with ALS
  • Scientists reveal a potential new approach to treating liver cancer
  • Normalizing tumor blood vessels may improve immunotherapy against brain cancer
  • Engineered bacteria find tumors, then alert the authorities
  • First nasal monoclonal antibody treatment for COVID-19 shows promise for treating virus, other diseases

Conferences & Events

  • SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
  • SAE Media Group's 6th annual 3D Cell Culture Conference
  • CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
  • 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
  • CPHI Excellence in Pharma Award Winners 2022
  • CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
  • CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index

Regulatory Affairs

  • FDA grants Accelerated Approval for Alzheimer's disease treatment
  • FDA approves new HIV drug for adults with limited treatment options
  • FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
  • FDA approves first gene therapy to treat adults with Hemophilia B
  • FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
  1. You are here:  
  2. Home
  3. Research
  4. 'Biohybrid' device could restore function in paralysed limbs

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2023. All Rights Reserved.